BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17343223)

  • 1. Isolation of mycobacterium leprae from untreated borderline tuberculoid, mid-borderline and indeterminate cases using the mouse foot pad technique--a study of 209 cases.
    Wakade AV; Shetty VP
    Lepr Rev; 2006 Dec; 77(4):366-70. PubMed ID: 17343223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of radiorespirometric Budemeyer assay with ATP assay and mouse foot pad test in detecting viable Mycobacterium leprae from clinical samples.
    Agrawal VP; Shetty VP
    Indian J Med Microbiol; 2007 Oct; 25(4):358-63. PubMed ID: 18087085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-100 as a useful auxiliary diagnostic aid in tuberculoid leprosy.
    Gupta SK; Nigam S; Mandal AK; Kumar V
    J Cutan Pathol; 2006 Jul; 33(7):482-6. PubMed ID: 16872470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.
    Gupta UD; Katoch K; Natarajan M; Sharma VD; Sharma RK; Shivannavar CT; Katoch VM
    Acta Leprol; 1997; 10(4):209-12. PubMed ID: 9447254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
    Shetty VP; Wakade A; Antia NH
    Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin smear examination in paucibacillary leprosy patients.
    Bhatia VN
    Indian J Lepr; 1991; 63(2):209-12. PubMed ID: 1783789
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative assessment of viability of M.leprae by mouse foot-pad and fluorescent staining techniques.
    Sreevatsa ; Katoch VM
    Indian J Lepr; 1994; 66(4):455-62. PubMed ID: 7714355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral lesion in leprosy: borderline tuberculoid diagnosis based on detection of Mycobacterium leprae DNA by qPCR.
    da Silva Martinez T; Nahas AA; Figueira MM; Costa AV; Gonçalves MA; Goulart LR; Goulart IM
    Acta Derm Venereol; 2011 Oct; 91(6):704-7. PubMed ID: 21879249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing between relapse and late reversal reaction in multidrug (MDT)-treated BT leprosy.
    Waters MF
    Lepr Rev; 2001 Sep; 72(3):250-3. PubMed ID: 11715270
    [No Abstract]   [Full Text] [Related]  

  • 10. Histopathological lesions of apparently normal skin in leprosy patients.
    Rashed HA; Mearag I; Saleh NM; Saied A
    J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay.
    Gupta UD; Katoch K; Sharma RK; Singh HB; Natragan M; Singh D; Sharma VD; Chauhan DS; Das R; Srivastava K; Katoch VM
    Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):328-34. PubMed ID: 12035294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial Mitsuda tests for identification of reactional tuberculoid and reactional borderline leprosy forms.
    Lastoria LC; Opromolla DV; Fleury RN; Habermann F; Curi PR
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):190-200. PubMed ID: 9728451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of the ICRC bacilli in the foot-pad of mice.
    Bapat CV; Modak MS
    Lepr India; 1978 Apr; 50(2):144-55. PubMed ID: 353383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of diagnostic role of in situ PCR on slit-skin smears in pediatric leprosy.
    Kamal R; Natrajan M; Katoch K; Katoch VM
    Indian J Lepr; 2010; 82(4):195-200. PubMed ID: 21434596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy.
    Shetty VP; Wakade AV; Ghate S; Pai VV; Ganapati R; Antia NH
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):210-7. PubMed ID: 14608816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of polymerase chain reaction in the diagnosis of early leprosy.
    Job CK; Jayakumar J; Williams DL; Gillis TP
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):461-4. PubMed ID: 9465155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse foot pad growth of M. leprae in relation to bacteriological index.
    Bhatia VN; Balakrishnan S; Venkataramaniah HN; Harikrishnan S
    Lepr India; 1983 Apr; 55(2):247-51. PubMed ID: 6355651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of changes in the nasal mucosa in indeterminate, tuberculoid and borderline leprosy.
    Chacko CJ; Bhanu T; Victor V; Alexander R; Taylor PM; Job CK
    Lepr India; 1979 Jan; 51(1):8-22. PubMed ID: 376945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the mouse foot pad test with a Buddemeyer type radiorespirometric assay in detecting viable Mycobacterium leprae in human lesional biopsies.
    Agrawal VP; Shetty VP
    Indian J Dermatol Venereol Leprol; 2007; 73(6):384-8. PubMed ID: 18032855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.